1. Home
  2. IXHL vs ECOR Comparison

IXHL vs ECOR Comparison

Compare IXHL & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$3.63

Market Cap

45.0M

Sector

N/A

ML Signal

HOLD

Logo electroCore Inc.

ECOR

electroCore Inc.

HOLD

Current Price

$6.79

Market Cap

49.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IXHL
ECOR
Founded
2001
2005
Country
Australia
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.0M
49.1M
IPO Year
2024
2018

Fundamental Metrics

Financial Performance
Metric
IXHL
ECOR
Price
$3.63
$6.79
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$18.00
AVG Volume (30 Days)
459.9K
81.7K
Earning Date
05-14-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$12,000.00
$32,032,000.00
Revenue This Year
N/A
$33.60
Revenue Next Year
N/A
$30.40
P/E Ratio
N/A
N/A
Revenue Growth
N/A
27.20
52 Week Low
$0.11
$4.16
52 Week High
$6.39
$8.55

Technical Indicators

Market Signals
Indicator
IXHL
ECOR
Relative Strength Index (RSI) 60.51 52.41
Support Level $0.34 $6.57
Resistance Level $3.68 $7.38
Average True Range (ATR) 0.34 0.65
MACD 0.01 0.02
Stochastic Oscillator 88.72 56.75

Price Performance

Historical Comparison
IXHL
ECOR

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

About ECOR electroCore Inc.

electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.

Share on Social Networks: